Skip Menu
Carol A. Moinpour
Affiliate Professor
Member
Fred Hutchinson Cancer Research Center

Carol Moinpour coordinates quality of life research (both treatment and prevention trials) for the Southwest Oncology Group (SWOG) Statistical Center/Fred Hutchinson Cancer Research Center (FHCRC). Dr. Moinpour also works with other behavioral scientists from both the Cancer Prevention Research Program and the Clinical Division at FHCRC. Dr. Moinpour's national committee involvement: Behavioral and Health Outcomes Subcommittee of SWOG's Cancer Control Research Committee, Mayo Clinic Clinical Significance of Quality of Life Scores Working Group; Cancer Outcomes Measurement Working Group (National Cancer Institute [NCI]); Intergroup Quality of Life Committee (NCI); National Surgical Adjuvant Breast and Bowel Project Quality of Life Committee.

Research Interests:
Assessment and interpretation of quality of life outcomes in cancer clinical trials; recruitment and adherence issues in clinical trial

Contact Information

email:   cmoinpou@fhcrc.org

address:
Southwest Oncology Group Statistical Center
Fred Hutchinson Cancer Research Center
1100 Fairview Ave. East M3-C102, Box 19024
Seattle, WA 98109-1024

voice:   206-667-4604
fax:   206-667-4408

Education

PhD   University of Washington, 1973   (Psychology)
MA   Ohio State University, 1965   (Psychology)
BS   Ohio State University, 1963   (History)

Recent Publications



Zeliadt SB, Penson DF, Moinpour CM, Blough DK, Fedorenko CR, Hall IJ, Smith JL, Ekwueme DU, Thompson IM, Keane TE, Ramsey SD. Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancer. BJU Int. 2011 Sep;108(6):851-6; discussion 856-7. doi: 10.1111/j.1464-410X.2010.09945.x. Epub 2011 Jan 18.  PMID: 21244609


Rim SH, Hall IJ, Fairweather ME, Fedorenko CR, Ekwueme DU, Smith JL, Thompson IM, Keane TE, Penson DF, Moinpour CM, Zeliadt SB, Ramsey SD. Considering racial and ethnic preferences in communication and interactions among the patient, family member, and physician following diagnosis of localized prostate cancer: study of a US population. Int J Gen Med. 2011;4:481-6. Epub 2011 Jun 17.  PMID: 21760749    PMCID: PMC3133516


Ramsey SD, Zeliadt SB, Fedorenko CR, Blough DK, Moinpour CM, Hall IJ, Smith JL, Ekwueme DU, Fairweather ME, Thompson IM, Keane TE, Penson DF. Patient preferences and urologist recommendations among local-stage prostate cancer patients who present for initial consultation and second opinions. World J Urol. 2011 Feb;29(1):3-9. Epub 2010 Oct 20.  PMID: 20959991


Zeliadt SB, Moinpour CM, Blough DK, Penson DF, Hall IJ, Smith JL, Ekwueme DU, Thompson IM, Keane TE, Ramsey SD. Preliminary treatment considerations among men with newly diagnosed prostate cancer. Am J Manag Care. 2010 May 1;16(5):e121-30.  PMID: 20455638


Penson DF, Zeliadt SB, Moinpour CM, Hall IJ, Lee Smith JW, Fedorenko CR, Thompson IM, Keane TE, Ramsey SD. Race and shared decision making among prostate cancer patients, family members, and physicians. American Urological Association, Chicago, IL. J Urol 181(4S): 26; 2009.